NOVEL ORAL ANTICOAGULANTS ARE SAFE AND EFFECTIVE FOR THROMBOEMBOLIC PROPHYLAXIS IN OBESE PATIENTS WITH ATRIAL FIBRILLATION
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)31132-3
Abstract: The prevalence of obesity in U.S. adults is 38% and class III obesity (BMI ≥40 kg/m2) approaches 8%, many have comorbid atrial fibrillation (AF). Recent recommendations caution against novel oral anticoagulant (NOAC) use for thromboembolic… read more here.
Keywords: atrial fibrillation; novel oral; obese patients; thromboembolic prophylaxis ... See more keywords
Venous thromboembolism prophylaxis of the obese postpartum patient: A cross‐sectional study
Sign Up to like & getrecommendations! Published in 2019 at "Australian and New Zealand Journal of Obstetrics and Gynaecology"
DOI: 10.1111/ajo.13054
Abstract: Obesity increases risk of venous thromboembolism (VTE) in obstetric patients regardless of delivery mode and for up to six weeks postpartum. read more here.
Keywords: obese postpartum; thromboembolism prophylaxis; thromboembolism; venous thromboembolism ... See more keywords